Skip to main content

Tag: ADHD

Drug Makers Are Advocacy Group’s Biggest Donors

By Gardiner Harris

Source: New York Times

WASHINGTON — A majority of the donations made to the National Alliance on Mental Illness, one of the nation’s most influential disease advocacy groups, have come from drug makers in recent years, according to Congressional investigators.

The alliance, known as NAMI, has long been criticized for coordinating some of its lobbying efforts with drug makers and for pushing legislation that also benefits industry.

Continue reading

Generation of Kids Hooked on Psych Drugs

By Evelyn Pringle

Source: http://www.lawyersandsettlements.com/blog/generation-of-kids-hooked-on-psych-drugs-0449.html

Campbell Brown anchors a daily prime-time news program on CNN. On June 17, 2009, in a segment of the program called the “Great Debate,” the question was, Ritalin, Prozac, Adderall, are we “pushing pills on our kids and raising a generation hooked on meds.”

Featured in the debate were, Kelly O’Meara, author of the book, “Psyched Out: How Psychiatry Sells Mental Illness and Pushes Pills that Kill,” and Dr Charles Sophy, a psychiatrist in private practice in Los Angeles, who serves as medical director of the LA County Department of Children and Family Services. They were each given 30 seconds for an opening statement.

Continue reading

Stimulants for ADHD Shown to Cause Sudden Death in Children

By Dr. Peter Breggin
June 17, 2009

A new study, published Monday in the American Journal of Psychiatry, confirms what I’ve been warning about for years in my scientific books and articles. The stimulants used to treat children for so-called ADHD can cause sudden cardiac arrest and death in kids. The study was published by the journal online in advance of regular publication in the near future. On Monday, I had the opportunity to comment on the study on Good Morning America. Here is more detail.

The stimulant group of drugs includes amphetamines like Adderall and Dexedrine and methylphenidate products such as Ritalin, Concerta, and Focalin. The study focused on Ritalin because at the time it was more commonly used than the amphetamines, although amphetamines are probably even more toxic to the heart.

The results of the study were as dramatic as they are tragic. Children and youth age 7 to 19 taking prescribed Ritalin for ADHD were four to five times more likely to die of sudden unexplained cardiac arrest than other children who were not taking Ritalin.

Despite these ominous results, the study was skewed to hide just how many children die of sudden death when taking Ritalin. The study relied heavily on identifying cases through toxicology reports at autopsy. But autopsy studies for the detection of these controlled substances are geared to detect more massive doses from addiction and overdose. They are not sensitive enough to detect many cases of routine prescription use. As a result, many stimulant-caused deaths were probably missed.

Also, the study excluded a large number of sudden deaths if the children had even the slightest evidence of pre-existing heart disease. They excluded these children even when the coroner thought that heart disease played no role in the death. For example, if a child was taking stimulants and had minimal heart disease, such as a slightly enlarged heart, the researchers didn’t include the case as a possible death due to the stimulant. They also did not count children who were severely obese, anorexic, or asthmatic. But all of these children, especially ones with undetected heart disease, are much more highly at risk for of stimulant-induced sudden death. They even excluded children whose parents had some forms of heart disease.

It’s as if they did not want to confirm the obvious—that an examination of children with heart disease and related disorders would swell the numbers of those killed by Ritalin. In fact, the current FDA approved label specifically mentions the risk of cardiac sudden death when Ritalin is given to children with heart conditions.

Unconscionable, the study researchers were trying not to prove that stimulants cause sudden death in children. They made the findings despite their own attempts to avoid it. I was not surprised to find that some of the researchers for this study are among the biggest advocates of psychiatric medications for children.

Sudden cardiac death in children is rare, probably occurring—as the study notes—in a slightly little less than 1 in 100,000 children. But we need to take a few other facts into account. First, the rate is going to be much higher in children taking stimulant drugs. Not just the four or five times higher found in this study, but many more times higher when vulnerable children are included such as those with undetected heart disease, severe obesity, asthma, or anorexia. Second, stimulant drugs are one of the few causes of cardiac death in otherwise normal children, making it impossible to detect the risk before it happens.

There is also evidence from studies of stimulant addicts and case reports that stimulant drugs can cause heart disease, including inflammation and scarring. When drugs like Ritalin and Adderall are prescribed in routine pediatric doses, they commonly cause hypertension, which can lead to an enlarged heart. Yet children with even slightly enlarged hearts were excluded from the study. So the researchers ended up excluding any children with enlarged hearts caused by the stimulant treatment itself.

The same is true in regard to anorexia. Stimulants commonly cause anorexia. The researchers therefore excluded cases of stimulant-induced death in anorexic patients when the anorexia itself could have been caused by the stimulant.

Meanwhile the psychiatric establishment—represented by American Psychiatric Association, NIMH and drug companies–has been quick to dismiss the importance of the study. Instead, they should be emphasizing that the study detected the risk even though the highest risk patients were excluded, including some who were displaying toxic stimulant effects such as heart disease and anorexia.

Meanwhile, it’s hard to imagine a greater tragedy for the surviving family than the unexpected death of a child from taking a medication prescribed by a doctor. I’ve been involved as a medical expert or consultant for families in several tragic cases of stimulant-induced cardiac death. I’ve also been an expert in cases of suicide in children caused by stimulants. These tragic deaths are always heartbreaking. Years afterward, the emotional wounds remain as raw as ever for their parents and brothers and sisters. The family’s trust for doctors and the healthcare system can be forever shattered.

Yet the answer to this problem is simple. Don’t give stimulants to children. There are far better non-drug ways to deal with so-called ADHD. ADHD is defined as involving hyperactivity, inattention, and impulsivity. These are not diseases—they are disciplinary and educational problems. Very often these children improve dramatically when parents develop a more consistent, rational and loving plan for discipline. Sometimes the problem completely disappears when the child is assigned a better teacher.

At times the child diagnosed with ADHD is simply a little delayed in learning self-discipline or finding the motivation to study. Often something is distressing the youngster, such as peer ridicule and abuse. Or the child may be especially full of life and need more opportunity to run, to play, and to be creative.

Whatever these children need, they don’t need toxic drugs that can lead to drug addiction, cause psychosis and depression, stunt growth, impair brain function, and even cause sudden cardiac arrest. I describe and document all of these adverse stimulant effects, and many more, in my medical book, Brain-Disabling Treatments in Psychiatry: Drugs, Electroshock, and the Psychopharmaceutical Complex, Second Edition (2008).

Our children don’t need drugs—they need us to protect them from misguided health professionals while we make every effort to meet their real needs in our families and schools. It’s time for all of us to retake responsibility for our children.

Dr. Breggin’s latest book is Medication Madness: The Role of Psychiatric Drugs in Cases of Violence, Suicide and Crime (St. Martin’s, 2008). It is now in paperback.

Dr. Breggin’s website is www.breggin.com
Email: psychiatricdrugfacts@hotmail.com

ADHD Drugs Linked to Sudden Death

Some Parents Believe New Study Reinforces Link Between Stimulants, Cardiac Death

Source: Article by Dan Childs and Todd Neale, ABC News

For Ann Hohmann, Oct. 21, 2004, began just about like any other day.

On that morning, the 54-year-old mother of two living in McAllen, Texas, was preparing to take her eldest son to school. She had an early appointment, so her husband, Rick Hohmann, would be dropping off younger son, 14-year-old Matthew, at his school that day.

Continue reading

Are We All Going Mad, Or Are The Experts Crazy?

LA Times Opinion Page

By Stuart A. Kirk, STUART A. KIRK is a professor of social welfare at UCLA. He is the coauthor of “The Selling of DSM” and “Making Us Crazy.” His most recent book is “Mental Disorders in the Social Environment”.

PSYCHIATRIC researchers recently estimated that half of the American population has had or will have a mental disorder at some time in their life. A generation ago, by contrast, only a small percentage of the American population was considered mentally ill. Are we all going mad?

Continue reading

Is Your ADHD Support Group a Front Organization for the Pharmaceutical Industry?

By Richard DeGrandpre, Ph.D.

On May 18, 1999, the New York Times reported that “social phobia ranks today as the third most prevalent psychiatric disorder in the United States……….affecting an estimated 19 million Americans, according to the Anxiety Disorders Association of America. Many are to bashful even to talk to therapists.” In the same week, the Boston Globe reported that “Epidemiological studies have found that acute social anxiety is the third most common psychiatric disorder in the United States………. affecting up to 13 percent of Americans. Jerilyn Ross, president of the Anxiety Disorders Association of America……she hopes a publicity blitz planned by………..SmithKline Beecham will raise awareness of social anxiety disorder and lead more people to seek help, which could include psychotherapy instead of drugs.” Why were the Boston Globe and the New York Times both writing about “social phobia disorder” in the same week, and why would a drug company spend its money to “raise awareness” of a mental-health disorder? The answer: the FDA had just approved a drug for the treatment of social phobia. As the Boston Globe put it, SmithKline Beecham makes the drug Paxil, which was “the first drug approved by the FDA specifically for treating social anxiety disorder.”

Continue reading

‘Shut Up and Pass the Prozac’ – Top Psychiatrist, Pro-Family Advocates Left Out of National Debate on Mental Health

By Debbie Thurman, Christian Communication Network

MONROE, Va., July 18 /Christian Wire Service/– “Shut up and pass the Prozac.” That is the consensus of the media in the most volatile round of psycho trash talk in recent memory. Since Tom Cruise kicked it up a notch on the “Today” show with Matt Lauer, all manner of “experts” have weighed in on both sides of the debate.

One of the most articulate and credentialed critics of current psychiatric practices was notably absent, however. Dr. Peter Breggin of The International Center for the Study of Psychiatry and Psychology, was essentially shut out of the debate by the media, at one point being forced to watch a 90-minute-long exchange between Jane Pauley and CNBC’s Donny Deutche, which he was invited to join by link-up, but to which he was never asked to contribute a comment.

Continue reading

Arianna’s Call For Drug-Violence Investigation Never More Timely

By Kelly Preston

Kirstie Alley and I recently supported 20 doctors from various health care fields, including family physicians, pediatricians, psychiatrists, researchers, nutritionists and surgeons in a letter to the FDA calling on it to strengthen its warnings on stimulants and antidepressants, especially when prescribed to children.

This was in response to the FDA’s recent warning that not only do antidepressants cause hostility and suicidal behavior in children, but also stimulant drugs [June 28 FDA advisory]. The doctors’ letter states: “We can no longer sit back and let the clock tick, waiting for more deaths, suicides or people driven to violent acts by psychotropic drugs. The FDA must continue to be vigilant, to root out other substances that have — one way or the other — slipped under the radar screen, and are now wreaking havoc with the nation’s youth.”

Continue reading

Lawmaker Calls for Registry of Drug Firms Paying Doctors

New York Times, by Gardiner Harris

WASHINGTON, Aug. 3 — An influential Republican senator says he will propose legislation requiring drug makers to disclose the payments they make to doctors for services like consulting, lectures and attendance at seminars.

The lawmaker, Charles E. Grassley of Iowa, the senior Republican on the Senate Finance Committee, cited as an example the case of a prominent child psychiatrist, who he said made $180,000 over just two years from the maker of an antipsychotic drug now widely prescribed for children.

Continue reading

St. Petersburg Times, Letters to the Editor

I am the mother of a 16-year-old autistic son. First, autism is not a mental illness. There are physical situations that precede the condition. The best definition I ever heard came from Bob Doman, the founder of the National Association for Child Development, when he told me he referred to autism as “brain toxicity.”

Continue reading

Skyrocketing Numbers of Kids Are Prescribed Powerful Antipsychotic Drugs. Is It Safe? Nobody Knows.

The ‘atypical’ dilemma

By Robert Farley, Times Staff Writer

More and more, parents at wit’s end are begging doctors to help them calm their aggressive children or control their kids with ADHD. More and more, doctors are prescribing powerful antipsychotic drugs.

In the past seven years, the number of Florida children prescribed such drugs has increased some 250 percent. Last year, more than 18,000 state kids on Medicaid were given prescriptions for antipsychotic drugs.

Continue reading

The New Face Of Antidepressants?

By Ed Silverman

For the past three years, the controversy over antidepressants has largely centered on exploring links between the pills and suicidal behavior, particularly in youngsters. But there has also been considerable chatter about homicidal thoughts.

Several killings around the country have prompted defense lawyers to blame an antidepressant for a killing. Most famously, this occurred in South Carolina, where 12-year-old Chris Pittman claimed Pfizer’s Zoloft prompted him to kill his grandparents. And one of the Columbine killers was prescribed Luvox.

Continue reading

Grassley Seeks Marketing and Safety Documents From Major Drug Maker

WASHINGTON – Sen. Chuck Grassley is asking the drug maker, Eli Lilly and Company, for information related to the risks and marketing of the anti-psychotic drug Zyprexa.

Grassley made this request in response to allegations that the company downplayed safety risks and engaged in other improper marketing practices that may be jeopardizing patients’ health. The text of Grassley’s letter follows here.

Continue reading

Showdown Looms in Congress Over Drug Advertising on TV

By Milt Freudenheim, The New York Times.

Drug advertising aimed at consumers, a fast-growing category that reached $4.5 billion last year, will face hard scrutiny in the new Congress, according to industry critics in both the House and Senate.

The consumer ads will be on the griddle early in this session at hearings on the user fees that manufacturers pay to speed the reviewing of new drugs by the Food and Drug Administration. The user fee law will die in the fall unless Congress acts to renew it.

Continue reading

Parents Join State Legislators in Calling for Investigation into School Shootings and Psychiatric Drug Use

Patricia Weathers
President
www.ablechild.org
(845) 677-8115

Sheila Matthews
National Vice President
www.ablechild.org
(203) 966-8419

Three school shootings in the past week have left 11 dead and 29 wounded, prompting the Bush administration to call for a school violence summit with education and law enforcement officials to help communities prevent violence and deal with its aftermath. Yet parents and legislators say that the government has consistently ignored the correlation between school shooters and psychiatric drug use and are likely to do so again at the upcoming summit.

Last year, following the Red Lake Minnesota school shootings and the revelation that the shooter Jeff Weise was under the influence of the antidepressant Prozac, a coalition of Tribal leaders and National Foundation of Women Legislators (NFWL) issued a joint resolution calling on Congress to fully investigate the correlation between psychiatric drug use and school shooters that had left 29 dead and 62 wounded. Ablechild also requested an investigation at that time.

The joint resolution called for such an investigation “to include all autopsies, toxicology reports, dosages of drugs that school shooters were either taking or withdrawing from, and testimony from medical experts who have exposed the dangers of these events”.

To date Congress has not acted upon this request. Nearly a year later, the Rocky Mountain News reported that Colorado school shooter Duane Morrison had an antidepressant in his car. Morrison took several girls hostage, killing one of them before committing suicide.

The evidence tying psychiatric drugs to acts of violence continues to mount; the FDA has warned that antidepressants can cause suicidal ideation, mania, and psychosis. The manufacturers of one antidepressant, Effexor, warn the drug can cause homicidal ideation. And earlier this month a study published in the Public Library of Science-Medicine journal found that the antidepressant Paxil raises the risk of violence. Though the study focuses specifically on Paxil, the researchers concluded that antidepressant drugs such as Prozac, Celexa, and Zoloft most likely pose the same risk. Lead researcher of the study, Dr. David Healy, director of Cardiff’s University’s North Wales Department of Psychological Medicine stated, “We’ve got good evidence that the drugs can make people violent and you’d have to reason from that that there may be more episodes of violence.”

AbleChild.org, a national grassroots parent’s organization, calls on all concerned citizens to contact their federal representatives, urging them to conduct a full investigation into the link between the spate of school shootings and possible psychiatric drug use of the shooters. Furthermore, state officials must demand full toxicology reports on all three recent school shooters to determine psychiatric drug usage or withdrawal. The victim’s families and the public at large deserve no less.